Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Anegon

Showing results (11-20 of 203) with videos related to

Pageof 21
Sort By:
Current Gene Therapy|January 31, 2015
Preface. Genes don't careIgnacio Anegon, Tuan H Nguyen
Transplantation|April 25, 2018
Advances on CD8+ Treg Cells and Their Potential in TransplantationSéverine Bézie, Ignacio Anegon, Carole Guillonneau
Immunotherapy|April 29, 2011
Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancerThomas Simon, Ignacio Anegon, Philippe Blancou
Current Opinion in Organ Transplantation|October 1, 2010
CD8+ regulatory T cells in solid organ transplantationCarole Guillonneau, Elodie Picarda, Ignacio Anegon
Cellular and Molecular Life Sciences : CMLS|March 5, 2017
Immunoregulatory properties of the cytokine IL-34Carole Guillonneau, Séverine Bézie, Ignacio Anegon
Transplantation|January 25, 2017
Improved Analyses of CD8+ T Cell Specificities Using Multimers of Peptide MHC Complexes Coupled to DNA BarcodesCarole Guillonneau, Laurent David, Ignacio Anegon
Immunotherapy|April 29, 2011
T-cell receptor specificity of CD8(+) Tregs in allotransplantationElodie Picarda, Ignacio Anegon, Carole Guillonneau
Therapeutic Drug Monitoring|May 29, 2004
Application of gene transfer technologies to transplantationIgnacio Anegon, Carole Guillonneau, Marcelo Hill, et al.
Immunotherapy|January 18, 2018
Immunotherapies in transplantation and cancer: 22nd NAT meeting/2nd NAT LabEx IGO joint meeting; 1-2 June 2017, Nantes, FranceSylvain Simon, Maud Charpentier, Ignacio Anegon, et al.
Immunological Reviews|October 9, 2019
Future prospects for CD8<sup>+</sup> regulatory T cells in immune toleranceLéa Flippe, Séverine Bézie, Ignacio Anegon, et al.
Pageof 21

Showing results (11-20 of 203) with videos related to

Sort By:
Pageof 21
Current Gene Therapy|January 31, 2015
Preface. Genes don't careIgnacio Anegon, Tuan H Nguyen
Transplantation|April 25, 2018
Advances on CD8+ Treg Cells and Their Potential in TransplantationSéverine Bézie, Ignacio Anegon, Carole Guillonneau
Immunotherapy|April 29, 2011
Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancerThomas Simon, Ignacio Anegon, Philippe Blancou
Current Opinion in Organ Transplantation|October 1, 2010
CD8+ regulatory T cells in solid organ transplantationCarole Guillonneau, Elodie Picarda, Ignacio Anegon
Cellular and Molecular Life Sciences : CMLS|March 5, 2017
Immunoregulatory properties of the cytokine IL-34Carole Guillonneau, Séverine Bézie, Ignacio Anegon
Transplantation|January 25, 2017
Improved Analyses of CD8+ T Cell Specificities Using Multimers of Peptide MHC Complexes Coupled to DNA BarcodesCarole Guillonneau, Laurent David, Ignacio Anegon
Immunotherapy|April 29, 2011
T-cell receptor specificity of CD8(+) Tregs in allotransplantationElodie Picarda, Ignacio Anegon, Carole Guillonneau
Therapeutic Drug Monitoring|May 29, 2004
Application of gene transfer technologies to transplantationIgnacio Anegon, Carole Guillonneau, Marcelo Hill, et al.
Immunotherapy|January 18, 2018
Immunotherapies in transplantation and cancer: 22nd NAT meeting/2nd NAT LabEx IGO joint meeting; 1-2 June 2017, Nantes, FranceSylvain Simon, Maud Charpentier, Ignacio Anegon, et al.
Immunological Reviews|October 9, 2019
Future prospects for CD8<sup>+</sup> regulatory T cells in immune toleranceLéa Flippe, Séverine Bézie, Ignacio Anegon, et al.
Pageof 21